nad has been researched along with Diseases, Metabolic in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (8.33) | 29.6817 |
2010's | 16 (44.44) | 24.3611 |
2020's | 11 (30.56) | 2.80 |
Authors | Studies |
---|---|
Diab, J; Ferrario, E; Strømland, Ø; Sverkeli, LJ; Ziegler, M | 1 |
Afzaal, A; Akash, MSH; Kamal, S; Rehman, K | 1 |
Bacino, C; Calame, D; Elsea, SH; Fisher, K; Gijavanekar, C; Hunter, J; Manor, J; Mizerik, E; Scaglia, F | 1 |
Christodoulou, J; Linster, CL; Patraskaki, M; Sikora, T; Van Bergen, NJ; Walvekar, AS | 1 |
Tian, D; Wang, H; Wang, M; Xi, P; Zhang, Y; Zhu, W | 1 |
Araki, SI; Kitada, M; Koya, D | 1 |
Aguilar-Arnal, L; Becerril-Pérez, F; Bustamante-Zepeda, M; Carreño-Vázquez, E; Escalante-Covarrubias, Q; González-Suárez, M; Mass-Sánchez, P; Mendoza-Viveros, L; Orozco-Solís, R; Pacheco-Bernal, I; Sitten-Olea, R; Velázquez-Villegas, LA | 1 |
Borén, J; Doganay, HL; Jin, H; Li, X; Mardinoglu, A; Nielsen, J; Ozturk, G; Turkez, H; Uhlén, M; Yang, H; Zhang, C | 1 |
Jalil, A; Masson, D; Thomas, C | 1 |
Gao, W; Huang, C; Huber, PE; Li, C; Shen, G; Xie, N; Zhang, L; Zhou, X; Zou, B | 1 |
A Nasser, S; Al-Dhaheri, Y; Bhagani, H; Dakroub, A; Eid, AA; Eid, AH; El-Yazbi, AF; Pintus, G; Younis, N | 1 |
Kim, JY; Koh, JH | 1 |
Becker-Kettern, J; Conrotte, JF; Fiehn, O; Jung, PP; Linster, CL; Paczia, N; Steinmetz, LM; Zhu, C | 1 |
Kane, AE; Sinclair, DA | 1 |
Nakagawa, T; Okabe, K; Tobe, K; Yaku, K | 1 |
Di Stefano, G; Manerba, M; Vettraino, M | 1 |
Assadi-Porter, FM; Bolandnazar, Z; Bütz, DE; Haviland, JA; Porter, WP; Selen, ES; Tonelli, M | 1 |
Auwerx, J; Cantó, C; Menzies, KJ | 1 |
Becherer, JD; Billin, AN; Carpenter, T; Chen, J; Chiang, SH; Geske, RS; Haffner, CD; Harrington, WW; Kramer, HF; Luo, G; Milliken, NO; Murray, R; Preugschat, F; Qian, Y; Rajpal, DK; Stimpson, SA; Ulrich, JC | 1 |
Alexopoulos, NA; Kallikazaros, IE; Katsi, VK; Liakos, CI; Makris, TK; Marketou, ME; Nihoyannopoulos, P; Pavlidis, AN; Raftopoulos, LG; Tousoulis, D | 1 |
Yamaguchi, S; Yoshino, J | 1 |
Bedalov, A; Chowdhury, S; Simon, JA | 1 |
Baric, I; Danhauser, K; Distelmaier, F; Haack, TB; Herebian, D; Klee, D; Klopstock, T; Kremer, LS; Lohmeier, K; Mayatepek, E; Mayr, JA; Meitinger, T; Müller-Felber, W; Petkovic Ramadža, D; Piekutowska-Abramczuk, D; Prokisch, H; Pronicka, E; Płoski, R; Rokicki, D; Schneider, D; Seibt, A; Strom, TM | 1 |
Auwerx, J; Cantó, C; Houtkooper, RH; Wanders, RJ | 1 |
Aljada, A; Dong, L; Mousa, SA | 1 |
Auwerx, J; Cantó, C | 1 |
Auwerx, J; Houtkooper, RH | 1 |
Guarente, L; Lin, SJ | 1 |
BELLODI, G; TONELLI, M | 1 |
SEGNI, G | 1 |
BENJAMIN, W; GELLHORN, A | 1 |
FISCHER, D; HARTLEYB, H; HEIDT, P; LAUSECKER, C; LOHR, GW | 1 |
BRITTINGER, G; KOENIG, E; LOEFFLER, G | 1 |
Booth, MP; Brady, RL; Mdluli, K; Rumsby, G | 1 |
Nabeshima, Y; Tanaka, T | 1 |
Uda, S | 1 |
18 review(s) available for nad and Diseases, Metabolic
Article | Year |
---|---|
The balance between NAD
Topics: ADP-ribosyl Cyclase 1; Aging; Animals; Armadillo Domain Proteins; Cognitive Dysfunction; Cytoskeletal Proteins; Drug Discovery; Humans; Metabolic Diseases; NAD; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Signal Transduction; Sirtuins | 2021 |
Versatile role of sirtuins in metabolic disorders: From modulation of mitochondrial function to therapeutic interventions.
Topics: Animals; Cardiomegaly; Humans; Metabolic Diseases; Mitochondria; NAD; Sirtuins | 2022 |
NAXE deficiency: A neurometabolic disorder of NAD(P)HX repair amenable for metabolic correction.
Topics: Animals; Humans; Metabolic Diseases; NAD; NADP; Racemases and Epimerases | 2022 |
Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency.
Topics: Humans; Metabolic Diseases; Mitochondria; NAD; Racemases and Epimerases; Seizures | 2022 |
The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research.
Topics: ADP-ribosyl Cyclase 1; Aging; Humans; Inflammation; Metabolic Diseases; NAD | 2023 |
NAD
Topics: Aging; Cyclic ADP-Ribose; Humans; Metabolic Diseases; NAD; NADP; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction | 2020 |
Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Metabolic Diseases; Models, Biological; NAD; Nicotinamide Phosphoribosyltransferase | 2020 |
Role of PGC-1α in the Mitochondrial NAD
Topics: Animals; Humans; Metabolic Diseases; Mitochondria; NAD; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction; Sirtuins; Transcription Factors | 2021 |
Sirtuins and NAD
Topics: Age Factors; Aging; Animals; Cardiovascular Diseases; Cardiovascular System; Enzyme Activation; Enzyme Activators; Humans; Metabolic Diseases; NAD; Sirtuins; Up-Regulation | 2018 |
Implications of altered NAD metabolism in metabolic disorders.
Topics: Diet; Humans; Metabolic Diseases; NAD | 2019 |
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases.
Topics: Humans; Metabolic Diseases; NAD; Neoplasms; Neurodegenerative Diseases | 2013 |
NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.
Topics: Aging; Animals; Cell Nucleus; Energy Metabolism; Homeostasis; Humans; Metabolic Diseases; Mitochondria; Molecular Targeted Therapy; NAD; Neoplasms; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Sirtuins | 2015 |
The Tree of Sirtuins and the Garden of Cardiovascular Youth.
Topics: Age Factors; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Energy Metabolism; Humans; Metabolic Diseases; NAD; Sirtuins | 2016 |
[The pathophysiological importance and therapeutic potential of NAD+ biosynthesis in age-related diseases].
Topics: Aging; Animals; Feedback, Physiological; Humans; Metabolic Diseases; NAD; Neoplasms | 2015 |
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.
Topics: Animals; Humans; Metabolic Diseases; NAD; Oxidoreductases; Signal Transduction; Transcription, Genetic | 2010 |
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
Topics: Alzheimer Disease; Drug Delivery Systems; Group III Histone Deacetylases; Histone Deacetylases; Humans; Longevity; Metabolic Diseases; NAD; Neurodegenerative Diseases; Saccharomyces cerevisiae; Sirtuins | 2010 |
Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?
Topics: Animals; Drug Discovery; Energy Metabolism; Humans; Metabolic Diseases; NAD; Protein Conformation; Sirtuin 1; Substrate Specificity | 2012 |
Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease.
Topics: Aging; Animals; Eukaryotic Cells; Genes, Regulator; Humans; Longevity; Metabolic Diseases; NAD; Sirtuins | 2003 |
1 trial(s) available for nad and Diseases, Metabolic
Article | Year |
---|---|
The acute effect of different NAD
Topics: Humans; Metabolic Diseases; NAD; Neurodegenerative Diseases; Niacin; Niacinamide; Nicotinamide Mononucleotide | 2023 |
17 other study(ies) available for nad and Diseases, Metabolic
Article | Year |
---|---|
Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet.
Topics: Animals; Body Composition; Diet, High-Fat; Metabolic Diseases; Mice; NAD; Nicotinamide Mononucleotide; Obesity; Sirtuins | 2023 |
Time-of-day defines NAD
Topics: Animals; Circadian Clocks; Circadian Rhythm; Diet; Female; Liver; Male; Metabolic Diseases; Mice; NAD | 2023 |
Fatty acids getting NAD+ about cardiometabolic diseases.
Topics: Cardiovascular Diseases; Fatty Acids; Humans; Metabolic Diseases; NAD | 2019 |
NAD(P)HX repair deficiency causes central metabolic perturbations in yeast and human cells.
Topics: Cells, Cultured; Humans; Metabolic Diseases; Metabolome; NAD; NADP; Racemases and Epimerases; Saccharomyces cerevisiae; Serine | 2018 |
NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
Topics: Amino Acids; Animals; Biomarkers; Citric Acid Cycle; Disease Models, Animal; Female; Glucocorticoids; Humans; Hydroxybutyrates; Kidney; Magnetic Resonance Spectroscopy; Metabolic Diseases; Metabolome; Metabolomics; Mice; Mitochondria; NAD; Oxidative Stress; Pentose Phosphate Pathway; Polycystic Ovary Syndrome | 2015 |
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Cyclic ADP-Ribose; Diet, Western; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; NAD; Oxidation-Reduction; Physical Conditioning, Animal | 2015 |
Biology, Chemistry, and Pharmacology of Sirtuins.
Topics: Acetylation; Animals; Drug Discovery; Enzyme Inhibitors; Histones; Humans; Metabolic Diseases; NAD; Neoplasms; Sirtuins; Small Molecule Libraries | 2016 |
NAXE Mutations Disrupt the Cellular NAD(P)HX Repair System and Cause a Lethal Neurometabolic Disorder of Early Childhood.
Topics: Carrier Proteins; Cell Line; Child, Preschool; Fatal Outcome; Female; Fibroblasts; Humans; Infant; Male; Metabolic Diseases; Mutation; NAD; Nervous System Diseases; Neuroimaging; Racemases and Epimerases; Skin Abnormalities | 2016 |
Exploring the therapeutic space around NAD+.
Topics: ADP-ribosyl Cyclase; Energy Metabolism; Humans; Metabolic Diseases; Mitochondria; Mitochondrial Diseases; NAD; Poly(ADP-ribose) Polymerases; Signal Transduction; Sirtuins | 2012 |
[The therapy of dysmetabolic states with biologically active coenzymatic complexes].
Topics: Avitaminosis; Coenzyme A; Coenzymes; Flavin Mononucleotide; Flavin-Adenine Dinucleotide; Humans; Metabolic Diseases; NAD; NADP; Thiamine Pyrophosphate; Vitamin B 12 | 1963 |
[FURTHER CONTRIBUTIONS TO THE ENZYMOPATHY OF FAVISM].
Topics: Aldehyde-Lyases; Favism; Glutathione; Humans; Metabolic Diseases; Metabolism; Methemoglobin; NAD; NADP; Oxidoreductases | 1964 |
THE INTRACELLULAR LOCALIZATION OF AN ENZYMATIC DEFECT OF LIPID METABOLISM IN DIABETIC RATS.
Topics: Adipose Tissue; Animals; Chromatography; Diabetes Mellitus, Experimental; Insulin; Lipid Metabolism; Liver; Manometry; Metabolic Diseases; Microsomes; NAD; NADP; Oleic Acid; Oxygenases; Pharmacology; Rats; Research; Stearic Acids | 1964 |
[A NEW CASE OF RECESSIVE CONGENITAL METHEMOGLOBINEMIA LINKED WITH A DIAPHORASE I DEFICIENCY].
Topics: Ascorbic Acid; Cytochrome-B(5) Reductase; Dihydrolipoamide Dehydrogenase; Drug Therapy; Genetics, Medical; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Metabolic Diseases; Methemoglobinemia; Methylene Blue; NAD; NADP | 1964 |
[CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA IN FAMILIAL DPNH AND TPNH-DEPENDENT GLUTATHIONE REDUCTASE DEFICIENCY OF THE ERYTHROCYTES. I].
Topics: Anemia; Anemia, Hemolytic, Congenital Nonspherocytic; Erythrocytes; Genetics, Medical; Glutathione; Glutathione Reductase; Humans; Metabolic Diseases; NAD; NADP; Oxidoreductases; Splenomegaly | 1965 |
A preliminary account of the properties of recombinant human Glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism.
Topics: Alcohol Oxidoreductases; Catalysis; Glyoxylates; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Metabolic Diseases; NAD; NADP; Oxidation-Reduction; Recombinant Proteins; Substrate Specificity | 2005 |
Nampt/PBEF/Visfatin: a new player in beta cell physiology and in metabolic diseases?
Topics: Animals; Humans; Insulin-Secreting Cells; Metabolic Diseases; Models, Biological; NAD; Nicotinamide Phosphoribosyltransferase | 2007 |
[Protein metabolic disorders in reference to molecular biology].
Topics: Adult; Animals; DNA; gamma-Globulins; Hemoglobins; Humans; Insulin; Male; Metabolic Diseases; Mice; NAD; Proteins; Rabbits | 1967 |